Spend some time over on the ENDV Board. They are in the same shape as BIEL as far as operating on a very limited budget. They did not develop the Sofpulse, they bought the rights from Rio Grande a year ago. Rio Grande sold because after 9 years they had not made the 'prescription model' profitable with Sofpulse.
Moving to the 'OTC model' is absolutely the right business plan for ActiPatch to pursue.
News 
Market Data 
Discover 
